TickerGuard
Buy Day today: Neutral (45) Mixed market breadth · no major macro event
SCTX

Scribe Therapeutics Inc.

Healthcare · Biotechnology

15.80$ +3.0% vs. previous close Closing price · As of: Nov 17, 2026

Ownership

Ownership Structure

Who owns Scribe Therapeutics Inc. (SCTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 33.7% of the shares are freely tradable; institutional investors hold 53.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 53.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 11.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 33.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 19Mio.

Largest Shareholders

Institutions

Institutions SCTX
Name Stake (%) Shares Change (%) Date
Sanofi 2.84 500,000 +0.0 09/30/2026

Funds

Funds SCTX
Name Stake (%) Shares Change (%) Date
ARK Genomic Revolution ETF 7.43 1,305,629 +0.6 10/29/2026
T. Rowe Price Health Sciences 3.89 683,719 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.65 290,561 +1,779.3 09/30/2026
iShares Russell 2000 ETF 1.40 246,215 +0.0 10/30/2026
Franklin Biotechnology Discv A(acc)USD 1.39 244,433 +0.0 09/30/2026
Franklin Biotechnology Discovery A 0.77 135,567 +0.0 09/30/2026
ARK Genomic Revolution ETF A USD Acc 0.43 74,865 +0.0 10/31/2026
Vanguard Russell 2000 ETF 0.32 56,244 +11,148.8 09/30/2026
iShares Russell 2000 Growth ETF 0.30 53,040 -0.4 10/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?